Aprepitant Sensitizes Acute Myeloid Leukemia Cells to the Cytotoxic Effects of Cytosine Arabinoside in vitro and in vivo

References

• GoldmanSL, HassanC, KhunteM, et al. Epigenetic modifications in acute myeloid leukemia: prognosis, treatment, and heterogeneity. Front Genet. 2019;10:133. doi:10.3389/fgene.2019.0013330881380
   PubMed Web of Science ®Google Scholar
• KansalR. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification. Cancer Biol Med. 2016;13(1):41–54. doi:10.20892/j.issn.2095-3941.2016.000127144061
   PubMed Web of Science ®Google Scholar
• FernandezC, Santos-SilvaMC, LopezA, et al. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis. Leukemia. 2013;27(11):2149–2156. doi:10.1038/leu.2013.10923579575
   PubMed Web of Science ®Google Scholar
• DohnerH, WeisdorfDJ, BloomfieldCD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra140618426376137
   PubMed Web of Science ®Google Scholar
• OranB, WeisdorfDJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97(12):1916–1924. doi:10.3324/haematol.2012.06610022773600
   PubMed Web of Science ®Google Scholar
• WayangankarSA, PatelBC, ParekhHD, HolterJL, LazzaraR. High-dose cytosine arabinoside-induced symptomatic bradycardia. J Cardiovasc Med (Hagerstown). 2015;16(Suppl 1):S38–S41. doi:10.2459/JCM.0b013e328341d0e521178637
   PubMed Web of Science ®Google Scholar
• NurgatZA, AlzahraniH, LawrenceM, et al. Intracranial hypertension secondary to high dose cytosine arabinoside - a case study. J Infect Chemother. 2017;23(5):319–322. doi:10.1016/j.jiac.2016.11.00528011351
   PubMed Web of Science ®Google Scholar
• LvY, ShaoG, ZhangQ, et al. The antimicrobial peptide PFR induces necroptosis mediated by ER stress and elevated cytoplasmic calcium and mitochondrial ROS levels: cooperation with Ara-C to act against acute myeloid leukemia. Signal Transduct Target Ther. 2019;4:38. doi:10.1038/s41392-019-0073-631637016
   PubMed Web of Science ®Google Scholar
• SteinhoffMS, von MentzerB, GeppettiP, PothoulakisC, BunnettNW. Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev. 2014;94(1):265–301. doi:10.1152/physrev.00031.201324382888
   PubMed Web of Science ®Google Scholar
• FuCY, YangQ, WangKR, KongZQ, ChenQ, WangR. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level. Behav Brain Res. 2006;170(2):293–301. doi:10.1016/j.bbr.2006.03.00716621052
   PubMed Web of Science ®Google Scholar
• FuCY, KongZQ, LongY, ChenQ, WangR. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: systemic study in anesthetized rats. Eur J Pharmacol. 2007;572(2–3):175–181. doi:10.1016/j.ejphar.2007.06.01417628523
   PubMed Web of Science ®Google Scholar
• FuCY, ZhaoYL, DongL, ChenQ, NiJM, WangR. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1 (4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain Behav Immun. 2008;22(6):850–860. doi:10.1016/j.bbi.2007.12.01018262387
   PubMed Web of Science ®Google Scholar
• MunozM, CovenasR, EstebanF, RedondoM. The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J Biosci. 2015;40(2):441–463. doi:10.1007/s12038-015-9530-825963269
   PubMed Web of Science ®Google Scholar
• GarnierA, VykoukalJ, HubertusJ, et al. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells. Int J Oncol. 2015;47(1):151–160. doi:10.3892/ijo.2015.301625998227
   PubMed Web of Science ®Google Scholar
• ZhouY, ZuoD, WangM, et al. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells. Genes Cells. 2014;19(9):676–691. doi:10.1111/gtc.1216825130457
   PubMed Web of Science ®Google Scholar
• MunozM, BergerM, RossoM, Gonzalez-OrtegaA, CarranzaA, CovenasR. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts. Int J Oncol. 2014;44(1):137–146. doi:10.3892/ijo.2013.216424190675
   PubMed Web of Science ®Google Scholar
• ZhangYX, LiXF, YuanGQ, et al. beta-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition. J Biol Chem. 2017;292(21):8933–8947. doi:10.1074/jbc.M116.77042028341744
   PubMed Web of Science ®Google Scholar
• DengXT, TangSM, WuPY, et al. SP/NK-1R promotes gallbladder cancer cell proliferation and migration. J Cell Mol Med. 2019;23(12):7961–7973. doi:10.1111/jcmm.1423030903649
   PubMed Web of Science ®Google Scholar
• MunozM, RossoM, CovenasR. A new frontier in the treatment of cancer: NK-1 receptor antagonists. Curr Med Chem. 2010;17(6):504–516. doi:10.2174/09298671079041630820015033
   PubMed Web of Science ®Google Scholar
• YuanDM, LiQ, ZhangQ, et al. Efficacy and safety of neurokinin-1 receptor antagonists for prevention of chemotherapy-induced nausea and vomiting: systematic review and meta-analysis of randomized controlled trials. Asian Pac J Cancer Prev. 2016;17(4):1661–1675. doi:10.7314/APJCP.2016.17.4.166127221836
   PubMedGoogle Scholar
• MunozM, CovenasR. Safety of neurokinin-1 receptor antagonists. Expert Opin Drug Saf. 2013;12(5):673–685. doi:10.1517/14740338.2013.80405923706125
   PubMed Web of Science ®Google Scholar
• GeC, HuangH, HuangF, et al. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Proc Natl Acad Sci U S A. 2019;116(39):19635–19645. doi:10.1073/pnas.190899811631488714
   PubMed Web of Science ®Google Scholar
• KeppO, GalluzziL, LipinskiM, YuanJ, KroemerG. Cell death assays for drug discovery. Nat Rev Drug Discov. 2011;10(3):221–237. doi:10.1038/nrd337321358741
   PubMed Web of Science ®Google Scholar
• DegterevA, MakiJL, YuanJ. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 2013;20(2):366. doi:10.1038/cdd.2012.13323197295
   PubMed Web of Science ®Google Scholar
• Van NoordenCJ. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem. 2001;103(3):241–251. doi:10.1078/0065-1281-0060111482370
   PubMed Web of Science ®Google Scholar
• DohnerH, EsteyEH, AmadoriS, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453–474.19880497
   PubMed Web of Science ®Google Scholar
• WeickJK, KopeckyKJ, AppelbaumFR, et al. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood. 1996;88(8):2841–2851. doi:10.1182/blood.V88.8.2841.bloodjournal88828418874180
   PubMed Web of Science ®Google Scholar
• BishopJF, MatthewsJP, YoungGA, et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood. 1996;87(5):1710–1717. doi:10.1182/blood.V87.5.1710.17108634416
   PubMed Web of Science ®Google Scholar
• JensenDD, LieuT, HallsML, et al. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief. Sci Transl Med. 2017;9(392):eaal3447.28566424
   PubMed Web of Science ®Google Scholar
• RuizAL, MartínMVS Neurokinin-1 receptor antagonist composition for treatment of diseases and conditions of the respiratory tract. United States patent US 15/328,825. 2017.
   Google Scholar
• FernandezA, OrdonezR, ReiterRJ, Gonzalez-GallegoJ, MaurizJL. Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis. J Pineal Res. 2015;59(3):292–307. doi:10.1111/jpi.1226426201382
   PubMed Web of Science ®Google Scholar
• CorazzariM, GagliardiM, FimiaGM, PiacentiniM. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78. doi:10.3389/fonc.2017.0007828491820
   PubMed Web of Science ®Google Scholar
• CaiY, ArikkathJ, YangL, GuoML, PeriyasamyP, BuchS. Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy. 2016;12(2):225–244. doi:10.1080/15548627.2015.112136026902584
   PubMed Web of Science ®Google Scholar
• NakkaVP, Prakash-BabuP, VemugantiR. Crosstalk between endoplasmic reticulum stress, oxidative stress, and autophagy: potential therapeutic targets for acute CNS Injuries. Mol Neurobiol. 2016;53(1):532–544. doi:10.1007/s12035-014-9029-625482050
   PubMed Web of Science ®Google Scholar